Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases
Clinical trial NCT05903937 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05903937
- Sponsor
- Vastra Gotaland Region
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-31
- Primary completion
- 2024-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.